Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Autolus Therapeutics plc from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Autolus Therapeutics plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q2 2019 to Q3 2025.
  • Autolus Therapeutics plc Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $6.16M, a 24.5% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.16M -$2M -24.5% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $6.29M +$521K +9.04% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $5.93M +$177K +3.08% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $7.64M +$1.11M +17.1% 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $8.16M +$1.9M +30.4% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $5.76M 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $5.75M 31 Mar 2024 10-Q 17 May 2024
Q4 2023 $6.52M +$3.35M +105% 31 Dec 2023 10-K 21 Mar 2024
Q3 2023 $6.26M 30 Sep 2023 10-Q 09 Nov 2023
Q4 2022 $3.18M +$195K +6.54% 31 Dec 2022 20-F 07 Mar 2023
Q4 2021 $2.98M -$5.17M -63.4% 31 Dec 2021 20-F 10 Mar 2022
Q4 2020 $8.15M +$3.79M +87% 31 Dec 2020 20-F 04 Mar 2021
Q4 2019 $4.36M 31 Dec 2019 20-F 03 Mar 2020
Q3 2019 $4.14M 30 Sep 2019 6-K 07 Nov 2019
Q2 2019 $4.27M 30 Jun 2019 6-K 08 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.